Giant cell tumour of the maxilla
SYUKRA NM, NOORIZAN Y, SUHAIMI Y, KHAIRULl A, ISLAH W
Otorhinolarngology Department, Hospital Tengku Ampuan Afzan, Pahang, and Otorhinolarngology Department, International Islamic University of Malaysia, Pahang, Malaysia
Giant cell tumour (GCT) of the bone accounts for 5 to 9% of primary bone tumours. The most common affected sites are the long bones. Involvement of the craniofacial bones such as the maxilla is rare. Painful swelling is the most common presenting complain. Like all tumours, it is important to achieve complete resection. The management of recurrent GCT of the maxilla is challenging as complete resection is often difficult and risk of recurrence is high. Regardless of the pre-operative stage, recurrence rates have been reported to be between 40 and 60% in the first three years after surgery. Five to 7% of recurrent cases are malignant recurrence. Close surveillance is important to detect the possibility of recurrence. We report the case of a GTC that re-occurred after resection and discuss the difficulty in managing such a case.
Keywords: Giant Cell tumour, osteoclastoma, maxilla, craniofacial bone
Correspondence author: Nik Mohd Syukra Bin Nik Abdul Ghani, Otorinolaringology Department, Hospital Tengku Ampuan Afzan Kuantan, Pahang, Malaysia.
E mail: email@example.com
Brunei Int Med J. 2013; 9 (2): 137-140